To evaluate the impact of urologist learning curve (LC) for mpMRI-TRUS fusion biopsy on clinically significant PCa (sPCa) detection rate.
INTRODUCTION AND OBJECTIVES: The aim of this study was to evaluate the accuracy of magnetic resonance imaging (MRI) scoring system for prostate cancer detection in the peripheral zone (PZ) and the transition zone (TZ) using MRI/trans-rectal ultrasonography (US) fusion targeted biopsy as a reference standard.
METHODS: We retrospectively reviewed 762 patients who underwent 3-Tesla multi-parametric (mp)-MRI and the following MRI/US fusion targeted biopsy, all of which were performed by experienced urologists (10/2012-8/2015) . We excluded patients in whom MRI did not identify any suspicious lesions and radiologists who reported in less than 50 cases. Finally, 648 patients with 1255 suspicious lesions were included in this study. The mp-MRIs were reported on a 5-point Likert scale of suspicion. The UroStation â (Koelis, France) was used for the image fusion. Clinically significant cancer was defined as biopsy Gleason score 7.
RESULTS: Median age was 64 years, pre-biopsy prostatespecific antigen (PSA) level was 6.93 ng/ml and estimated prostate volume was 52.1 ml. Of 1255 suspicious lesions on MRI, 62.4% (n¼783) were located in the PZ and 19.5% (n¼245) in the TZ.There was no significant difference in the proportion of 5-point suspicious grades between the PZ and the TZ (p¼0.077). In comparison between the PZ and the TZ, there was no significant difference in overall cancer detection rate in grade 1-2 lesions (11.8% vs 15.1%, p¼0.362), grade 3 lesions (26.9% vs 19.8%, p¼0.163) and grade 4-5 lesions (55.4% vs 50.0%, p¼0.551). Regarding clinically significant cancer detection rate, there was no significant difference in grade 1-2 lesions between the PZ and the TZ (3.1% vs 6.6%, p¼0.087). In contrast, statistical differences were noted in grade 3 lesions (15.1% vs 5.9%, p¼0.019) and grade 4-5 lesions (45.9% vs 23.7%, p¼0.013) between the PZ and the TZ.
CONCLUSIONS: The diagnostic reliability of mp-MRI for detecting clinically significant cancer in the TZ was less than that in the PZ. Although grade 3 lesions in the TZ showed similar overall cancer detection rate compared to that in the PZ, clinically significant cancer detection rate of grade 3 lesions in the TZ was quite lower than that in the PZ. Improvement of radiologist's interpretation, grading system itself, or targeting technique for grade 3 lesions in the TZ should be reconsidered.
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MP03-20 DIAGNOSTIC PERFORMANCE OF APPARENT DIFFUSION COEFFICIENT BETWEEN THE PERIPHERAL ZONE AND TRANSITIONAL ZONE IN LOCALIZED PROSTATE CANCER
Jung Keun Lee*, In Jae Lee, Tae Jin Kim, Hakmin Lee, Jong Jin Oh, Sangchul Lee, Seong Jin Jeong, Seok-Soo Byun, Sang Eun Lee, Sung Kyu Hong, Seongnam, Korea, Republic of INTRODUCTION AND OBJECTIVES: Apparent diffusion coefficient (ADC) grade is increasingly reported in prostate magnetic resonance imaging (MRI). We evaluated the usefulness and limitations of ADC grade for peripheral zone (PZ) and transitional zone (TZ).
METHODS: We reviewed the data of 455 consecutive men who underwent 3.0 Tesla diffusion-weighted MRI before radical prostatectomy from January 2015 to May 2016. The level of suspicion from the ADC map was graded using the 5-grade Likert scale. Patients with a Likert grade 3 were included in the final analysis. The MRI index lesion was defined as the lesion with highest grade or the largest lesion when multiple lesions had an identical grade. After radical prostatectomy, topographic analyses were performed on the intraprostatic location of tumor foci at each specimen. The pathologic index tumor was defined as the tumor with the highest Gleason score or largest tumor when multiple foci had an identical GS. We matched the location between MRI index lesions and pathologic index tumors. The Vol. 197, No. 4S, Supplement, Friday, May 12, 2017 THE JOURNAL OF UROLOGY â e27
